Hypermethylation of FOXA1 and allelic loss of PTEN drive squamous differentiation and promote heterogeneity in bladder cancer Journal Article


Authors: Osei-Amponsa, V.; Buckwalter, J. M.; Shuman, L.; Zheng, Z.; Yamashita, H.; Walter, V.; Wildermuth, T.; Ellis-Mohl, J.; Liu, C.; Warrick, J. I.; Shantz, L. M.; Feehan, R. P.; Al-Ahmadie, H.; Mendelsohn, C.; Raman, J. D.; Kaestner, K. H.; Wu, X. R.; DeGraff, D. J.
Article Title: Hypermethylation of FOXA1 and allelic loss of PTEN drive squamous differentiation and promote heterogeneity in bladder cancer
Abstract: Intratumoral heterogeneity in bladder cancer is a barrier to accurate molecular sub-classification and treatment efficacy. However, individual cellular and mechanistic contributions to tumor heterogeneity are controversial. We examined potential mechanisms of FOXA1 and PTEN inactivation in bladder cancer and their contribution to tumor heterogeneity. These analyses were complemented with inactivation of FOXA1 and PTEN in intermediate and luminal mouse urothelium. We show inactivation and reduced expression of FOXA1 and PTEN is prevalent in human disease, where PTEN and FOXA1 are downregulated by allelic loss and site-specific DNA hypermethylation, respectively. Conditional inactivation of both Foxa1 and Pten in intermediate/luminal cells in mice results in development of bladder cancer exhibiting squamous features as well as enhanced sensitivity to a bladder-specific carcinogen. In addition, FOXA1 is hypermethylated in basal bladder cancer cell lines, and this is reversed by treatment with DNA methyltransferase inhibitors. By integrating human correlative and in vivo studies, we define a critical role for PTEN loss and epigenetic silencing of FOXA1 in heterogeneous human disease and show genetic targeting of luminal/intermediate cells in mice drives squamous differentiation. © 2019, The Author(s), under exclusive licence to Springer Nature Limited.
Keywords: immunohistochemistry; controlled study; human cell; promoter region; nonhuman; mouse; allele; animal tissue; hepatocyte nuclear factor 3alpha; gene expression; tumor differentiation; animal experiment; animal model; bladder cancer; dna methylation; urothelium; dna modification; drug mechanism; western blotting; phosphatidylinositol 3,4,5 trisphosphate 3 phosphatase; gene loss; gene inactivation; gene dosage; tumor gene; cancer morphology; genetic heterogeneity; carcinogen; pten gene; zebularine; foxa1 gene; decitabine; human; male; female; priority journal; article; bladder cancer cell line
Journal Title: Oncogene
Volume: 39
Issue: 6
ISSN: 0950-9232
Publisher: Nature Publishing Group  
Date Published: 2020-02-06
Start Page: 1302
End Page: 1317
Language: English
DOI: 10.1038/s41388-019-1063-4
PUBMED: 31636388
PROVIDER: scopus
DOI/URL:
Notes: Article -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors